Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients: a systematic review and meta-analysis

Fig. 3

Forest plot of (A) ORR and (B) OS in AML patients with cytogenetic abnormalities of RUNX1::RUNX1 T1. The diamonds represent the overall summary RR and HR estimates with 95% CI. RR < 1 indicates a reduced ORR in the VEN-HMAs group. Only 2 studies were available and the results should be taken with caution

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us